CoChat

DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care?

Open access
Clarke, Diana E., Kuhl, Emily A. · 2014 · World Psychiatry
Cited by 111

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The notion that psychiatric disorders occur along dimensional continua rather than as categorical entities has long been debated. Research and clinical evidence have illustrated that a categorical diagnostic schema does not accurately reflect the full realms of clinical concerns in many patients, such as the presence of subthreshold anxiety or psychotic symptoms in individuals with major depressive disorder that cause or exacerbate impairment and distress 1, 2. In some instances, clinicians are forced to diagnose two or three separate disorders, typically using the "not otherwise specified" label, in order to facilitate treatment for their patients 3. In the absence of a fully dimensional diagnostic schema, the integration of dimensional assessments of psychiatric symptomatology may be clinically useful in providing valuable information for our current understanding of mental disorders and the issue of co-occurring symptoms and conditions 1. In addition, the integration of categorical diagnoses and dimensional assessments of psychiatric symptoms may also facilitate the identification and fine-tuning of psychiatric endophenotypes, as emphasized in the Research Domain Criteria, for the various mental disorders 4. The DSM-5 Task Force and Work Groups developed and proposed the incorporation of dimensional measures – i.e., self-(i.e., adult and child/adolescent) and informant-report (i.e., parent/guardian) versions of the DSM-5 Cross-Cutting (CC) Symptom measures – to help address the issue of co-occurring symptoms across mental disorders 5-8. This paper discusses the benefits of the DSM-5 CC Symptom measures and identifies areas for further research and development. The self- and informant-reported versions of the DSM-5 CC Symptom measures were developed by the DSM-5 Task Force and Work Groups to serve as a "review of mental systems" in each patient who presents for mental health evaluation and treatment. The measures assess the presence and severity of 12-13 psychiatric symptom domains that cut across diagnostic boundaries 7, 8. These include depression, anger, mania, anxiety, somatic symptoms, sleep disturbance, psychosis, obsessive thoughts and behaviors, suicidal thoughts and behaviors, substance use (e.g., alcohol, nicotine, prescription medication, and illicit substance use), personality functioning, dissociation, and cognition/memory problems in adults. Many of the same domains, except for personality functioning, dissociation, and cognition/memory problems, are also assessed in children/adolescents, along with inattention and irritability. The co-occurrence and severity of these symptoms have been shown to significantly affect the prognosis and treatment of many mental disorders 1, 2, 9-11. The items on the DSM-5 CC Symptom measures do not relate to any specific disorder and as such are not intended to be diagnostic or to serve as screening measures for any disorder 8. Instead, the measures were developed to be used as adjunct tools "to give clinicians quantitative ratings that characterize patients in a way that is simple, useful, and clinically meaningful" 8. It is hoped that the information from these measures will inform clinical decision-making and treatment. For instance, the ability to characterize patients has the potential to lead to customizable treatment plans and improvement in treatment outcomes. However, future studies are needed to explore if and how these measures inform clinical decision-making. The DSM-5 CC Symptom measures are operationalized at two levels. Level 1 consists of a 23-item (adults) or a 25-item (children/adolescents) measure of the presence and severity of symptoms over the past two weeks 7, 8, 12. The items, with the exception of suicide ideation, suicide attempts, and substance use in children/adolescents, are rated on a 5-point scale (i.e., 0=none/never; 1=slight/rare; 2=mild/several days; 3=moderate/more than half the days; and 4=severe/almost daily), with higher scores indicating greater frequency of occurrence or greater degree of severity. The suicide ideation, suicide attempts, and substance use items on the child/adolescent version of the scale are scored on a yes/no basis. Items scored as 2 or greater (i.e., mild/several days) or with a "yes" trigger the completion of a more detailed assessment of that symptom domain using the associated self- or informant-reported DSM-5 Level 2 CC Symptom measure. Level 2 CC measures inquire about the presence and severity of symptoms within pure psychiatric domains during the past seven days (e.g., the Altman Mania Scale for a more detailed assessment of mania, given the respondent endorsed the Level 1 mania item at a score of 2 or greater). The intent is for all patients, regardless of DSM diagnoses, to complete the DSM-5 Level 1 and 2 CC Symptom measures routinely either at each clinic visit or at clinically-indicated intervals but prior to meeting with their clinicians. This would enable clinicians to track the presence,

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/wps.20154

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Clarke, D. E., & Kuhl, E. A.
Venue
World Psychiatry
Publisher
Wiley
Published
2014-10
Volume
13
Issue
3
Pages
314-316
ISSN
1723-8617 (ISSN-L)
OpenAlex
W1980369900
Cited by
111
References
6
FWCI
3.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.